Development of food kits with high nutritional and energy values, fortified with micronutrients, used to fight against childhood malnutrition, the debilitation of people living with HIV, pregnant women or any other nutritionally vulnerable patient.
Development of two photographic guides (one for children and one for adults) for food consumption studies.
Validation of bioelectrical impedancemetry and anthropometry equations for determining body composition.
Development, using methods using isotopes and in cooperation with the IRD and the IAEA, of a genetically modified mosquito incapable of transmitting malaria, the competitive multiplication of which will undoubtedly lead to the annihilation of the anopheles vector of the disease.
Development of an experimental model to induce obesity and diabetes; which makes it possible to study both diseases (pathophysiology, drug trials, etc.)
Development of recent HIV/AIDS screening technologies (transition from the manufacture of first generation tests to more effective third and fourth generation tests which take into account the genetic diversity of viral strains in Central Africa).
Expansion of the range of reagents usable in small health facilities with low technical capacity, such as public and private health centers.
Thanks to a technology transfer partnership with the French company for reagents and instruments (SFRI), specialized in human biology analyses, the IMPM has acquired a biotech unit for manufacturing biochemistry reagents and hematology systems adaptable to most machines available in national health facilities and the sub-region.
These results will lead to inexpensive pharmaceutical coverage in the country. The industrial scale production of these drugs as well as essential oils with proven effectiveness will not only make a considerable contribution to improving the health of populations, but also create jobs for farmers who will be able to deliver plant raw materials at IMPM. Sales proceeds will strengthen the Institute’s resources.
Development of two monographs on Cameroonian antimalarial and antidiabetic plants.
A patent for the invention of a process for manufacturing biscuits and their nine variants based on natural flours (natural corn and cocoa flour)
A patent for the invention of a process for manufacturing a toilet soap and its five variants based on natural oil and cocoa extracts
IRAD has been selected as one of the two centers for the Distinctness, Homogeneity and Distinctness (DHS) tests of the African Intellectual Property Organization (OAPI)
